Refractory warts: topical or intralesional cidofovir options

Published Date: 02 Mar 2023

New research suggests that cidofovir may be a helpful option for tender joints or joints.

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Maintenance Rituximab Improves Survival in Elderly MRD-Negative MCL Patients.

2.

New PET tracer enables same-day imaging of triple-negative breast and urothelial cancers

3.

Intractable cancers may respond better to treatment when using new radiation and high-performance computing.

4.

In Higher-Risk MDS, CMML, All-Oral Therapy Has Promise.

5.

improvements in the treatment of prostate cancer resistant to chemotherapy.


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot